Sabra C Lewsey1, Khadijah Breathett2. 1. Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Division of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.
Abstract
PURPOSE OF REVIEW: This review discusses the current state of racial and ethnic inequities in heart failure burden, outcomes, and management. This review also frames considerations for bridging disparities to optimize quality heart failure care across diverse communities. RECENT FINDINGS: Treatment options for heart failure have diversified and overall heart failure survival has improved with the advent of effective pharmacologic and nonpharmacologic therapies. With increased recognition, some racial/ethnic disparity gaps have narrowed whereas others in heart failure outcomes, utilization of therapies, and advanced therapy access persist or worsen. SUMMARY: Racial and ethnic minorities have the highest incidence, prevalence, and hospitalization rates from heart failure. In spite of improved therapies and overall survival, the mortality disparity gap in African American patients has widened over time. Racial/ethnic inequities in access to cardiovascular care, utilization of efficacious guideline-directed heart failure therapies, and allocation of advanced therapies may contribute to disparate outcomes. Strategic and earnest interventions considering social and structural determinants of health are critically needed to bridge racial/ethnic disparities, increase dissemination, and implementation of preventive and therapeutic measures, and collectively improve the health and longevity of patients with heart failure.
PURPOSE OF REVIEW: This review discusses the current state of racial and ethnic inequities in heart failure burden, outcomes, and management. This review also frames considerations for bridging disparities to optimize quality heart failure care across diverse communities. RECENT FINDINGS: Treatment options for heart failure have diversified and overall heart failure survival has improved with the advent of effective pharmacologic and nonpharmacologic therapies. With increased recognition, some racial/ethnic disparity gaps have narrowed whereas others in heart failure outcomes, utilization of therapies, and advanced therapy access persist or worsen. SUMMARY: Racial and ethnic minorities have the highest incidence, prevalence, and hospitalization rates from heart failure. In spite of improved therapies and overall survival, the mortality disparity gap in African American patients has widened over time. Racial/ethnic inequities in access to cardiovascular care, utilization of efficacious guideline-directed heart failure therapies, and allocation of advanced therapies may contribute to disparate outcomes. Strategic and earnest interventions considering social and structural determinants of health are critically needed to bridge racial/ethnic disparities, increase dissemination, and implementation of preventive and therapeutic measures, and collectively improve the health and longevity of patients with heart failure.
Authors: Angelo Auricchio; Christoph Stellbrink; Stefan Sack; Michael Block; Jürgen Vogt; Patricia Bakker; Christof Huth; Friedrich Schöndube; Ulrich Wolfhard; Dirk Böcker; Olaf Krahnefeld; Hans Kirkels Journal: J Am Coll Cardiol Date: 2002-06-19 Impact factor: 24.094
Authors: Peter Glynn; Donald M Lloyd-Jones; Matthew J Feinstein; Mercedes Carnethon; Sadiya S Khan Journal: J Am Coll Cardiol Date: 2019-05-14 Impact factor: 24.094
Authors: M Colvin; J M Smith; N Hadley; M A Skeans; K Uccellini; R Goff; J Foutz; A K Israni; J J Snyder; B L Kasiske Journal: Am J Transplant Date: 2020-01 Impact factor: 8.086
Authors: Alanna A Morris; Aditi Nayak; Yi-An Ko; Melroy D'Souza; G Michael Felker; Margaret M Redfield; W H Wilson Tang; Jeffrey M Testani; Javed Butler Journal: Circ Heart Fail Date: 2020-07-08 Impact factor: 8.790
Authors: Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Patches Johnson Inge; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy Journal: Circulation Date: 2010-07-26 Impact factor: 29.690
Authors: Salpy V Pamboukian; Maria Rosa Costanzo; Peter Meyer; Linda Bartlett; Mary McLeod; Alain Heroux Journal: J Card Fail Date: 2003-04 Impact factor: 5.712
Authors: Joseph Yeboah; Carlos J Rodriguez; Brandon Stacey; Joao A Lima; Songtao Liu; J Jeffrey Carr; W Gregory Hundley; David M Herrington Journal: Circulation Date: 2012-11-02 Impact factor: 29.690
Authors: Palak Shah; Sean Agbor-Enoh; Pramita Bagchi; Christopher R deFilippi; Angela Mercado; Gouqing Diao; Dave Jp Morales; Keyur B Shah; Samer S Najjar; Erika Feller; Steven Hsu; Maria E Rodrigo; Sabra C Lewsey; Moon Kyoo Jang; Charles Marboe; Gerald J Berry; Kiran K Khush; Hannah A Valantine Journal: J Heart Lung Transplant Date: 2022-06-28 Impact factor: 13.569
Authors: Reza Mohebi; Chen Chen; Nasrien E Ibrahim; Cian P McCarthy; Hanna K Gaggin; Daniel E Singer; Emily P Hyle; Jason H Wasfy; James L Januzzi Journal: J Am Coll Cardiol Date: 2022-08-09 Impact factor: 27.203
Authors: Omar Dewidar; Irina Podinic; Victoria Barbeau; Dilan Patel; Alba Antequera; David Birnie; Vivian Welch; George A Wells Journal: ESC Heart Fail Date: 2021-11-24